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Abstract 
Background: Using patient-reported outcome measures (PROMs) to assess Quality of Life 
(QoL) is well established, but commonly-used PROM item-sets do not necessarily capture what 
all respondents consider important. Measuring complex constructs is particularly difficult in 
randomised controlled trials (RCTs). The Mother-Generated Index (MGI) is a validated 
antenatal and postnatal QoL instrument in which the variables and scores are completely 
respondent-driven. This paper reports on the feasibility and acceptability of the MGI in an 
RCT, and compares the resulting variables and QoL scores with more commonly used 
instruments.   
Methods: The single-page MGI was included at the end of a ten page questionnaire pack and 
posted to the RCT participants at baseline (28-32 weeks’ gestation) and follow-up (six weeks 
postnatal).  Feasibility and acceptability were assessed by ease of administration, data entry 
and completion rates. Variables cited by women were analysed thematically. MGI QoL scores 
were compared with outcomes from the EQ-5D-3L; Edinburgh Postnatal Depression Scale; 
Satisfaction With Life Scale; and State Trait Anxiety Inventory. 
Results: 678 pregnant women returned the pack at baseline; 668 completed the MGI (98.5%); 
383/400 returns at follow up included a completed MGI (95.7%). Quantitative data were 
scanned into SPSS using a standard data scanning system, and were largely error-free; 
qualitative data were entered manually. The variables recorded by participants on the MGI 
forms incorporated many of those in the comparison instruments, and other outcomes 
commonly used in intrapartum trials, but they also revealed a wider range of issues affecting 
their quality of life. These included financial and work-related worries; moving house; and 
concerns over family illness and pets. The MGI scores demonstrated low-to-moderate 
correlation with other tools (all r values p<.01).  
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Conclusions: Without face-to-face explanation and at the end of a long questionnaire, the MGI 
was feasible to use, and acceptable to RCT participants. It allowed individual participants to 
include issues that were important to them, but which are not well captured by existing tools. 
The MGI unites the explanatory power of qualitative research with the comparative power of 
quantitative designs, is inexpensive to administer, and requires minimal linguistic and 
conceptual translation. 
 
Trial registration: ISRCTN27575146 
Keywords:  patient-reported outcome measure; randomised controlled trial; quality of life; 
pregnancy; antenatal; postnatal; feasibility; acceptability. 
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Background 
In terms of health care research, and especially randomised trials of effectiveness, death and 
serious morbidity tend to be the default primary outcomes. It is clearly useful to have common 
outcome measures so that data and results can be compared, and the COMET initiative [1]  
proposes the collection of core outcome sets within effectiveness trials.  Within maternity care 
there is also a move to encourage the use of ‘core’ outcome measures [2]. Nevertheless, studies 
have tended to cast their net widely when deciding what to measure. Smith et al’s [3] recent 
systematic review of Cochrane reviews concerning intrapartum studies identified 16 
salutogenic (positive, health generating) outcomes and 49 outcomes focused on pathological 
phenomenon. A further recent study in the area of preterm birth found that 72 outcome 
measures had been used across 103 studies [4].  This divergence has led to a call for the 
development of core outcome sets for research across women’s health [2]. The proponents of 
this call recognise the need to include the perspectives of the women who use these services.  
The attempt to be inclusive and comprehensive is welcome, but unlikely to be straightforward 
when those designing and funding RCTs tend to prioritise serious but rare outcomes (such as 
mortality) over more complex measures of experience and longer-term wellbeing that might 
apply to more of those in the general population – especially in maternity care where most 
women and babies are healthy. One solution has been the inclusion of patient-reported outcome 
measures (PROMs) to assess Quality of Life (QoL) [5-7] [8]. PROMs were originally 
developed to gauge the effectiveness of certain surgical procedures [6]. More recently, they 
have been expanded to a range of disciplines, in an attempt to “seek to ascertain patients’ views 
of their symptoms, their functional status, and their health-related quality of life” [9].  
 Despite the initial promise, it has been acknowledged that the wide range of  professionally-
derived proformas that are used to capture PROMs do not capture all the factors that matter to 
health service users [6]. It is difficult to square the need for an agreed and parsimonious core 
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set for populations with particular health care needs, while still capturing the large variation 
between individuals within that population. The ideal instrument would encompass the specific 
needs, wishes, and priorities of each individual while at the same time providing a valid and 
reliable objective measurement that is comparable across populations and between studies. A 
validated QoL tool in which the variables and scores are completely respondent driven, but 
which could also provide a numeric QoL score  would have utility not only in the assessment 
of clinical practice, but also as a key outcome measure in RCTs. This paper reports on the 
feasibility and acceptability of using one such tool, the Mother-Generated Index, in a trial 
context, and compares the resulting variables and QoL scores with more commonly used 
instruments.    
 
 
The Mother-Generated Index (MGI) 
The MGI was developed from the Patient-Generated Index (PGI) [10] which has been used 
extensively, but never in the context of an RCT [11]. The PGI was the first attempt to develop 
a tool responsive to individual patients’ particular experiences and concerns, and which also 
converted those highly personal issues to a single Quality of Life (QoL) score that could be 
compared across populations. The MGI, in allowing individual respondents to identify and then 
score and rank the most important areas of their life, encourages this subjective evaluation.  
The MGI is a one-page three-step questionnaire which generates a QoL score based on a list 
of variables that the mother herself identifies as being important in the context of the maternity 
care practice/intervention under examination. Because the variables the mother can record are 
not pre-specified,  the MGI does not lend itself to a standard psychometric analysis [12], yet it 
has shown good face, criterion and construct validity [13], and its feasibility, acceptibilty, 
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reliability and validity as a measure of maternity care in general have been established in 
observational and before-and-after studies within several linguistic and cultural groups in nine 
countries to date, and in both the antenatal and postnatal periods [14-17]. In all the studies to 
date participants were introduced to it during face to face interviews, although one postal 
follow-up has also been conducted [18]. 
In Step 1 of the MGI the woman records her subjective description of what is important to her. 
Based on how she has been affected over the previous month by these clinical, emotional, 
cultural and psycho-social concerns she then scores each area in Step 2 to produce a primary 
index of quality of life (range 0 [worst] to 10 [optimum]). This score, the average of the 
individual variable scores, can be compared objectively across whole populations. In Step 3 
she allocates ‘spending points’ to indicate the relative importance of the areas she has cited. 
Figure 1 provides an example of a completed MGI form.   
Figure 1 Example of completed MGI form 
We could not find any report of a completely respondent-driven PROM such as this being used 
within a trials context. We decided to include the MGI in a pre-trial pilot of the SHIP trial [19]. 
Positive results from this pilot convinced us to include it in the main trial. We therefore set out 
to examine whether the MGI was feasible and acceptable as a respondent-driven PROM within 
a randomised controlled trial. We believe this to be the first time that an individually patient-
generated postal PROM has been tested within the context of an RCT. 
 
The context 
The SHIP  (Self-Hypnosis for Intrapartum Pain) trial took place in seven sites across three NHS 
Trusts in the northwest of England, including a range of birth settings (free standing midwife 
led units, an alongside midwife led units, and three hospitals with birth rates of 10,300, 6,900, 
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and 4,500 in 2013). The Trusts covered both rural and urban populations with a range of socio-
demographic profiles. The trial assessed the effect of a group-based antenatal self-hypnosis 
education programme on rates of epidural use in labour.  Secondary outcomes included several 
measures of wellbeing and satisfaction using standard data collection tools. The 680 
participants were nulliparous women not planning elective caesarean, without medication for 
hypertension and without psychological illness. A ten-page questionnaire pack was sent by 
post to women in both the intervention and control groups at baseline (28-32 weeks), 36 weeks 
gestation, two weeks postnatally, and six weeks postnatally. The MGI was included at the end 
of the pack at baseline and six weeks postnatal. 
 
Methods 
Assessing feasibility and acceptibility of the MGI entailed an examination of how well the tool 
could be integrated into the questionnaire pack, how easily the data items could be scanned 
with a standard data scanning system,  an assessment of the percentage of participants who 
attempted the MGI even though it was at the end of a long questionniare pack, and  the average 
percentage of elements of the instrument completed, and completed correctly at both time 
points. The validity of the MGI had already been establised in a range of cultural contexts, so 
formal validation was not required. However, a comparision was made between the MGI QoL 
scores at both time points, and the same woman’s scores for several psychometric tools 
commonly used in maternity care service development and research. Finally, to test the 
hypothesis that a PROM based on what was important to each individual trial participant would 
capture different variables and concepts than commonly used tools in maternity care trials, we 
examined these data thematically, and compared them to the variables in the comparator tools 
in the SHIP trial, and to the outcomes that were recorded in a review of Cochrane reviews of 
intrapartum RCTs (Smith et al as above [3]).  
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Comparator instruments 
Four of the measures in the questionnaire pack were analysed as comparators for the MGI.  The 
EQ-5D-3L [20] includes questions regarding mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression. The Edinburgh Postnatal Depression Scale [21] is a 
widely-used ten-question screening instrument that is validated for both antenatal and postnatal 
use. The Satisfaction With Life Scale [SWLS] [22] is a five-item instrument measuring global 
cognitive judgements about life satisfaction. The questions relate to whether life is ideal or not, 
whether conditions are good, whether the respondent has achieved most of the things they want 
to achieve or would change things if they had the chance. The short version of the State Trait 
Anxiety Inventory [STAI] [23], a widely-used tool which measures anxiety, is said to produce 
similar scores to the full version. Between them, these instruments aimed to measure health 
status, satisfaction with life, anxiety and depression.  
 
Data entry 
As part of the whole questionnaire pack, the completed MGI results were scanned directly into 
the study database for each respondent, and this was overseen by the Clinical Trials Unit (CTU) 
associated with the study. The scanning software identified numerical responses. Narrative 
responses were entered into the database by hand.    
 
Analysis  
Regular quality checks within the CTU tracked data entry errors or unusual responses. 
Quantitative data from the questionnaires were analysed in SPSS. Simple percentages were 
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used to determine completion rates. Simple correlations using Pearson’s test were used to 
compare the MGI QoL score and those on the comparator tools.  
Each MGI form was also evaluated by a thematic analysis of the variables cited in Step 1; this 
was done independently by paired members of the team. Disagreements over themes were 
resolved at a team meeting. KF, AS and RK independently generated themes from the narrative 
data and matched the numeric data with the emergent themes to produce frequencies as well as 
the primary and secondary indices.   
We then compared this analysis with the components of these responses to the comparator tools 
and with the outcomes identified by Smith et al [3] in their systematic review of outcomes in 
the Cochrane Pregnancy and Childbirth database. 
 
Ethics approval was granted by an NHS IRAS Ethics Committee and by the University of 
Central Lancashire, Faculty of Health Ethics Committee. All participants were fully consented 
before recruitment to the study. This article presents independent research funded by the 
National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) 
Programme (Grant Reference Number PB-PG-0808-16234). The views expressed are those of 
the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. 
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Results 
The baseline survey at 28-32 weeks gestation was completed by 678/680 women (99.7%), and 
400 of these 678 completed the postal follow-up survey at 6 weeks (59%). Their socio-
demographic data at baseline are shown in Table 1. The socio-demographic characteristics of 
those at follow-up were broadly similar across all variables, the only exception being that those 
lost to attrition had slightly lower educational attainment (χ2=8.54; p<.05). 
Table 1 Socio-demographic characteristics of participants at baseline 
 
Feasibility of using the MGI within an RCT 
The MGI took up one page in the ten page questionniare pack and was easily integrated into 
theis. The Clinical Trials Unit reported that the scoring for Steps 2 and 3 of the MGI was picked 
up well by the scanning system they used, and that the data were largely free of errors (see 
below for details). However, the narrative data in the free text boxes (which described the 
variables of interest to each woman) had to be checked and entered by hand.  
 
Acceptability/ease of use 
The percentage of questionnaire respondents who recorded at least some response on the MGI 
component was 98.5% (668/678) at baseline  (338/342) [98.8%] intervention group and 
330/336 [98.2%] control group) and 95.7% (n=383/400) at 6 weeks postnatal (200/207 [96.6%] 
intervention group and 183/193 [94.8%] control group). At baseline, 94.8% (633/668) of 
respondents listed the maximum number of five issues in Step 1 of the MGI with 20 citing four 
issues, nine citing three, two citing two and four citing one. Completion of the MGI Step 1 was 
also high at six weeks postnatally: 91.6% (351/383) of participants listed five issues, 20 cited 
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four, six wrote three, four listed two and two cited one issue. All participants who completed a 
postnatal MGI form had also completed the baseline MGI. All participants at both time points 
were able to allocate a score at Step 2 of the MGI but 21.4% (142/662) of participants at 
baseline and 27.6% (103/383) of women six weeks postnatally did not allocate the Step 3 points 
correctly. These inaccuracies were largely due to using more or fewer than the 12 permitted 
points or not allocating any points at all. As the calculation of the QoL measure does not depend 
on Step 3 of the MGI, this did not affect the capacity of the instrument to measure QoL 
quantiatively. With face-to-face surveys any difficulties with form completion can be 
overcome; improving the instructions for Step 3 completion in future postal surveys should 
mitigate this problem.   
 
Comparison with other instruments  
The descriptive statistics for the various questionnaires are shown in Table 2. At baseline and 
postnatal follow-up the MGI showed statistically significant low-to-moderate correlations with 
all of the standard questionnaires. The lowest correlations were recorded against the EQ-5D. 
At baseline 64% (426/662) women scored ‘1’ (indicating perfect quality of life) on the EQ-5D; 
at follow-up (6 weeks postnatal) 60% did so (239/385). This suggests that the EQ-5D has very 
low discriminatory power for antenatal and postnatal women, who are largely healthy.  
Table 2 Standard psychometric measures: descriptive statistics and correlation 
with MGI  
 
Comparing the reported issues in the MGI with those in existing standard instruments and 
outcomes reported in a systematic review of reviews of intrapartum interventions. 
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At baseline the 668 respondents cited a total of 3,280 comments in the MGI. In addition, both 
Step 2 scores (reflecting how the woman had been affected by the cited issue over the previous 
month; possible range 0-10) and Step 3 scores (her relative ranking of importance; possible 
range 0-12) varied considerably (Table 3). 
Table 3 Frequency of cited comments at baseline (27 weeks gestation), with 
associated Step 2 and Step 3 scores  
 
The most commonly cited issues related to the woman’s partner, extended family, career / work 
concerns, and her own health and wellbeing. The woman’s wider social circle, issues regarding 
house and home, money, and the anticipated baby, were important too, although several other 
themes also emerged such as the transition to parenthood and concern over illness within the 
family. These themes partially echoed those variables included in standard item-sets and Smith 
et al’s [3] review of Cochrane reviews, but there were many which stood apart from these 
‘standard’ outcomes. 
Women who cited career and work issues gave them varying scores. Low-scoring comments 
(“Completing workload before I leave”, “Stress at work” and “Returning to work after 
maternity leave”) were balanced by more positively worded ones (“Good working 
relationships”, and “Being in a stable job and financially secure”). Money issues were 
commonly expressed, and these were mostly negative (“Feeling isolated and lonely due to 
money”, and “Not having enough money to get married or get a mortgage”). Many found 
themselves wanting or having to move house (“Finding a house”; “Getting a fixed address”) 
or preparing the home (“Getting the house ready for baby”). Less expected areas included 
concern over a friend whose baby had been born disabled, references to animals (“My pet cat 
being stressed at changes”; “My dog has cancer”), to hobbies and to faith and religion. 
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The 1,861 comments cited by 383 mothers at postnatal follow-up were categorised 
thematically, and the Step 2 and Step 3 scores analysed as before.  
Table 4 Frequency of cited comments at follow up (6 weeks postnatal), with 
associated Step 2 and Step 3 MGI scores 
 
As with the baseline comments these varied considerably. Most postnatal comments fell into 
fairly predictable categories, reflecting outcomes measured in other studies: joy or concern 
about the baby, relationship with partner and parents, personal health and wellbeing, and 
finding (or not finding) a routine or new social circle. This compares with Smith et al’s [3] 
review which identified (albeit in very small numbers) ‘Positive relationship with infant’, 
‘Wellbeing’ (her own and the partner’s), and ‘Views’ (again her own and her partner’s). 
However, the MGI identified some complexity in these issues, reflecting personal difficulties 
or sadness (“Relationship with baby’s father”; “Best friends leaving the area”; “Remembering 
my dad”). Several commented on the lack of ‘Me time’ (i.e. time to herself). While some 
comments expressed the happiness of the new or changing role (“Being a good mum”; “Making 
new friends through baby groups”; “Being able to socialise and drink again”), others revealed 
traumas (“Feeling out of control [unable to plan day/night due to feeding demands]”). One 
mother who cited “Post-traumatic stress brought on by nightmares due to care whilst in labour” 
did indeed have a higher than average STAI score. For some, other issues were important: one 
referred to starting her own business, and another to having to learn a script for a play. Religion 
(“Faith in God – Christianity”) and animals (“Exercising and bonding with dog”; “Making time 
for my two cats”; “My horses”) featured again. 
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Discussion 
This paper evaluates the incorporation of the MGI, a respondent-driven Patient-Reported 
Outcome Measure, as a postal QoL instrument within a randomised controlled trial of self-
hypnosis for labour pain amongst nulliparous women who were unselected for risk. We found 
the incorporation of the MGI to be feasible, acceptable and informative. Although the women 
had not seen the MGI beforehand, completion rates were encouragingly high at both baseline 
and follow-up, despite the fact that it was the last questionnaire within a ten-page study pack, 
and presumably the last to be completed. The high response rate and the generally accurate 
form completion indicate that this respondent-driven instrument is an acceptable way of 
determining quality of life as a trial outcome, but based authentically on what matters to each 
individual participant. Although the MGI only had low to moderate correlation with a range of 
instruments that are frequently used in maternity trials, we would suggest that this might be 
because the MGI is better at tapping issues that really matter to the individuals in the study, in 
contrast to the fixed variable sets in the existing tools. While some of the themes identified at 
baseline and follow-up were to be expected (‘partner’, ‘baby’, ‘extended family’ ‘work’, ‘house 
and home’), others were less predictable. The MGI allowed the women to raise issues like 
education, the health and wellbeing of significant others, financial issues and even pets and 
religion. In addition, they were able to score and rank these. These are aspects of their lives 
that most standard tools will not cover. 
An additional added value of the MGI is that it requires minimal conceptual and linguistic 
translation if it is just used as a measure of QoL. In this case, the variables recorded by the 
participants do not need to be translated, as what is of interest is the final numeric score. The 
instructions are brief and easily translated. The successful use of the MGI in a wide range of 
context, including India [15] Germany [16] Poland [24] and Iran [14] demonstrates its utility 
as an outcome measure that can transcend language and cultural barriers with relative ease. 
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This is a significant advantage for international multicentre studies and also for studies in a 
single country that include a wide range of cultural and language groups, as is often the case 
for those accessing maternity care.  
 
Strengths and weaknesses of the study 
The main strength of this study is that it was undertaken alongside a robust clinical trial with a 
very high response rate at baseline. While the trial did experience much lower responses at the 
six week follow up, this was no different for the MGI than for the other tools in the 
questionnaire package, and, at both time points very high percentages of respondents 
completed the MGI. Limitations included  variation in handwriting in self-completed forms, 
which made electronic scanning of free text entries problematic. As a consequence,  manual 
entry of comments was required. The fact that around one in five respondents did not complete 
Step 3 of the instrument correctly suggests that another limitation was a lack of clear 
instructions as to how to undertake this element of the tool. The order in which the various 
instruments were offered in the questionnaire pack may have affected what was cited in the 
MGI. Given that the tool depends on women to report what matters to them, it may be best to 
place it at the beginning of the pack, so that the items in the other instruments do not influence 
maternal responses. In fact, however, while some of the comments identified by participants 
reflected domains present in standard psychometric tools, many did not, so order of 
questionnaire completion did not seem to influence the MGI responses in this study.  
 
Strengths and weaknesses in relation to other studies 
To our knowledge no previous RCT has included an individualised respondent-driven PROM 
such as this, although many studies have used health status or specific quality of life 
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instruments. Basing quality of life assessment on the areas of life which the mother considers 
to be those most important to her avoids the pitfalls of a ‘top-down’ instrument which, however 
well prepared, may not reflect the woman’s current concerns [25]. Most of the women in this 
study cited partner or other family members as important considerations, yet, these variables 
are not usually included in the assessment of intrapartum outcomes in controlled trials in 
maternity care [3] and nor are they an element of the EQ-5D, STAI short version or the SWLS. 
The EPDS, a screening tool for maternal psychological wellbeing, does not even mention the 
baby, a factor in the new mother’s life that was worthy of note to almost all the mothers 
surveyed here. Other factors not covered by the standard tools but recorded as important by the 
respondents to this study included financial worries, the stress of moving house, anxiety 
concerning work or education, and the importance of friends.  
Satisfaction is commonly used as an indicator of patient experience, but this approach has been 
criticised because of a lack of standardisation and of reliability data [26]. The link between 
patient satisfaction and the health care system or health care quality and outcomes has been 
claimed to be unclear and even tenuous [27, 28]. In condition-specific cases a targeted quality 
of life evaluation may be required (e.g. [29]). However, the experience of pregnancy and new 
motherhood cannot be described as neatly as with a specific medical condition, and the MGI 
allows a holistic approach to be adopted that goes beyond satisfaction measures. The MGI has 
been used in the UK, Poland, Portugal, Brazil, Iran, China, India Germany and Switzerland 
[14-17, 24]. Given the very limited textual and conceptual translation that is needed for the 
data collection tool, the MGI in most cases is easily transferable into the full range of cultural 
and linguistic contexts in which maternity care is provided. Other tools, by contrast, often 
require sophisticated and expensive conceptual and linguistic fine-tuning to fit each context in 
which they are used.  
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Many tools are available in a range wide of languages, but this ease of use has potential pitfalls: 
if researchers assume they are measuring one construct when they are measuring another, then 
false inferences may be made.  The EQ-5D, for example, has been referred to as a ‘quality of 
life’ tool [[30]; [31]], although properly speaking it measures health status. Choice of tool must 
be informed by a clear understanding of what is being assessed. 
 
 
Implications for clinicians and policymakers 
The MGI is already recognised as a valuable tool for assessing women’s views and experiences 
of maternity care in general. Extending it as a key outcome measure for clinical trials would 
enable researchers to capture complex and nuanced variations in what matters to women. A 
QoL tool that allows scores to be compared numerically between intervention and control 
groups, and which also allows for more nuanced analysis of the issues that affected women in 
relation to the trial, adds a valuable extra layer of understanding. This can also be used as a 
basis for understanding the contextual factors that might influence the success or failure of the 
introduction of complex interventions into trials, opening up what has been called the ‘black 
box’ of the mechanisms of effect in such interventions [32]. These added insights might also 
enable more efficient transfer of knowledge from research to practice, as they could frame the 
way in which an intervention should be implemented if it is successful.  
 
Unanswered questions and future research 
The potential for the MGI to explain mechanisms of effect of interventions in trials, and for 
this to inform roll-out, needs to be assessed in future research. We would recommend that the 
MGI is tested further in future controlled studies of maternity care, and that the Patient-
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Generated Index is also considered for use in controlled trials in studies of health care in 
general. Apart from one postal follow-up, prior to the SHIP Trial the MGI had only been 
completed under the supervision or guidance of a researcher. However, given the excellent 
completion rates in this study there would appear to be scope to test the distribution of the tool 
on a variety of platforms including internet and mobile devices.  
The timing of the MGI’s application is an issue: it has been used in various studies from the 
late pregnancy to the immediate postnatal period and up to eight months following the baby’s 
birth. Since quality of life is dynamic, it will clearly identify different issues at different times. 
Large-scale longitudinal studies, including RCTs, would allow for the tracking of changing 
issues of concern and possible changing quality of life scores as well. Given the prominence 
of comments relating to partners in the SHIP study, and the known importance of social support 
during and after pregnancy [33, 34], it would be instructive to examine the quality of life of 
women and partners as dyads.  
 
Conclusion 
With greater demographic and workforce mobility there is increasing diversity within local 
populations; this complexity is a factor of modern contemporary health care and research. 
While Black [9] draws a distinction between PROMs and patient-reported experience measures 
(PREMs), in practice it may be difficult to separate out a patient’s perceptions of a clinical 
condition and their reported experience of clinical care related to this. We have demonstrated 
that the MGI is a feasible, acceptable, and value-added quality of life measure for assessment 
of outcome at two points in time in trials of maternity care. It unites the explanatory power of 
qualitative research with the comparative power of quantitative designs, is inexpensive to 
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administer (and would be even on a range of platforms) and, based on previous studies, it is 
easily translated to a range of cultural and linguistic contexts. 
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Figure 1 Example of completed Mother-Generated Index 
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Table 1 Socio-demographic characteristics of participants 
 
  Variable Total  Intervention 
 
Control 
 N n mean SD n mean SD 
Age 
 
 
672 337 28.4 5.5 335 28.5 5.2 
Gestation at 
randomization 
 
669 335 27.8  1.0 334 27.8 1.1 
 N n  n of 
event 
% n n of 
event 
% 
Education  
(% GCSE or below) 
665 333 70 21.0 332 54 16.3 
Ethnicity 
(% White) 
 
670 336 320 95.2 334 303 90.7 
BMI > 40  
(% at booking) 
 
672 337 8 2.4 335 9 2.7 
Income  
(% < £24,000 p/a) 
652 324 99 30.6 328 89 27.1 
Birth partner identified 
(% yes) 
669 335 331 98.8 334 334 100.0 
Type of Maternity Care 
(% midwife led) 
655 327 287 87.8 328 288 87.8 
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Table 2. Standard psychometric measures: descriptive statistics and correlation with 
MGI  
      Correlation with 
MGI 
  Mean SD Range IQR r p 
MGI Baseline 7.6 1.51 0-10 1.80 n/a  
 6 weeks PN 7.6 1.48 0-10 1.65 n/a  
EQ-5D-
3L 
Baseline .92 0.12 0.13-1 0.20 .225 p<.01 
 6 weeks PN .91 0.15 -.594-1 0.15 .226 p<.01 
EPDS Baseline 6.4 4.53 0-26 6.00 -.350 p<.01 
 6 weeks PN 4.9 4.41 0-22 6.00 -.395 p<.01 
SWLS Baseline 28.1 4.88 9-35 5.00 .464 p<.01 
 6 weeks PN 29.3 4.57 10-35 6.00 .334 p<.01 
STAI Baseline 10.2 3.52 6-22 5.00 -.255 p<.01 
 6 weeks PN 9.3 3.42 0-23 5.00 -.306 p<.01 
 
Key 
IQR  Interquartile Range 
EQ-5D-3L  Euroqol 5D [3L version] 
EPDS   Edinburgh Postnatal Depression Scale 
SWLS  Satisfaction With Life Scale 
STAI   State Trait Anxiety Inventory  
6 weeks PN  6 weeks postnatal 
  
 25 
Table 3.  Frequency of cited comments at baseline (27 weeks gestation), with associated 
MGI scores. 
  Step 2 scores Step 3 scores 
 Comments 
  
Mean SD Range Mean SD Range 
Partner 653 8.3 1.9 0-10 2.4 2.2 0-12 
Extended family 550 8.2 2.2 0-10 2.5 2.4 0-12 
Career / work 468 6.3 2.2 0-10 3.2 2.5 0-12 
Health / Wellbeing (Self) 314 7.5 2.4 0-10 2.9 2.2 0-12 
Friends 277 7.6 2.0 0-10 2.5 2.0 0-12 
House / Home issues 219 8.4 2.3 1-10 2.6 2.3 0-12 
Money 195 5.6 2.1 0-10 3.7 2.4 0-12 
Baby 186 8.7 1.8 0-10 3.1 2.4 0-12 
Transition: Preparation & Planning 147 8.2 1.8 3-10 2.9 2.3 0-12 
Becoming a Mother / Family 65 9.0 1.7 2-10 2.4 2.3 0-12 
Education 39 6.6 2.4 2-10 2.8 2.0 0-10 
Health / Wellbeing (Others) 34 6.2 3.0 0-10 5.0 3.8 1-12 
Animals / Pets 33 7.6 3.2 0-10 2.9 3.2 0-12 
Labour & Childbirth 22 4.7 3.1 1-10 4.2 3.2 1-12 
Faith / religion 13 8.5 1.9 5-10 5.2 3.3 2-12 
Other 65 6.6 2.7 0-10 3.3 3.0 0-12 
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Table 4.  Frequency of cited comments at baseline (6 weeks post-natal), with associated 
MGI scores. 
  Step 2 scores 
 
 
 
Step 3 scores 
 
 Comments Mean SD Range Mean SD Range 
Partner 364 8.4 1.8 0-10 2.7 2.0 0-12 
Baby 296 9.0 1.7 2-10 2.4 2.4 0-12 
Extended Family 267 8.5 1.7 0-10 2.2 2.2 0-10 
Friends 189 7.1 2.0 2-10 2.5 1.7 0-9 
Career/Work 144 5.8 2.4 0-10 3.1 2.4 0-12 
Becoming a Mother / Family 142 8.9 1.4 3-10 2.6 2.1 0-11 
Health/Wellbeing (Self) 137 6.2 2.5 0-10 3.5 2.4 0-12 
House/Home Issues 124 6.6 2.1 0-10 3.1 2.5 0-12 
Money 102 5.7 2.1 1-10 4.1 2.5 0-12 
Transition: Preparation & Planning 23 6.5 2.4 1-10 3.1 1.8 1-6 
Animals/Pets 16 7.0 2.9 0-10 3.3 2.6 0-9 
Education 12 5.2 2.7 1-10 5.2 3.7 1-12 
Health/Wellbeing (Others) 7 4.9 2.2 2-8 4.7 3.7 1-12 
Faith/Religion 5 8.4 1.4 7-10 3.8 1.9 2-7 
Other 33 6.2 3.2 0-10 3.4 2.8 1-12 
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